All UK & Rest of Europe articles – Page 84
-
NewsCoevolution and UV spectrum help Santa’s reindeer feast after flight
The eyes of Rudolph and his reindeer brethren may have evolved so that they can spot their favorite food - a lichen called reindeer moss - during dark and snowy Arctic winters.
-
NewsNovel bacteria identification methods might help speed up disease diagnosis
A new study applied spectroscopic techniques for quick analysis for identification of Pseudomonas aeruginosa directly from an object - in this case, turtle skin.
-
NewsMultiple sclerosis: Possible basis for vaccine researched
Researchers have shown that the risk of MS is particularly high in people with a combination of certain host factors and variants of the Epstein-Barr virus (EBV).
-
NewsNew research lays groundwork for personalized dietary supplements
Researchers used fluorescence-labeled inulin-grafted nanoparticles to track the interaction of inulin with gut bacteria - when incubated with human stool samples, a wider range of gut bacteria thatn previously assumed were found to bind to inulin.
-
NewsDenovAI uses artificial intelligence to discover therapeutic antibodies
Kashif Sadiq has founded a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advanced machine learning and computational biophysics.
-
NewsTeam-up of two new substances paves the way for new antibiotics
A new study shows how a combination of two new substances effectively kills methicillin-resistant Staphylococcus aureus (MRSA).
-
NewsCOVID-19 infection alters gene transcription of olfactory mucosal cells in Alzheimer’s disease
A new study identifies alterations in the transcriptomic signatures in human olfactory mucosal cells of individuals with Alzheimer’s disease following SARS-CoV-2 infection, potentially contributing to exacerbated COVID-19 outcomes.
-
NewsEMA gives positive opinion to first oral treatment of acute form of sleeping sickness
The EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense).
-
NewsOmicron induces cellular senescence in human lung, study finds
Researchers investigating the influence of defined altered spike formations have confirmed that the Omicron variant induces cellular senescence in human lungs of COVID-19 patients.
-
NewsRisk of death reduces after COVID-19 vaccine but protection wanes after six months
The risk of death from COVID-19 decreases significantly after vaccination but this protection diminishes after six months, providing evidence for continued booster doses, a new study has found.
-
NewsAncient DNA reveals how a chicken virus evolved to become more deadly
Scientists have used ancient DNA to trace the evolution of Marek’s Disease Virus (MDV), showing how viruses evolve to become more virulent and could lead to the development of better ways to treat viral infections.
-
NewsDiverse gut bacteria communities protect against harmful pathogens by nutrient blocking
A new study demonstrates that diverse communities of resident bacteria can protect the human gut from disease-causing microorganisms. However, this protective effect is lost when only single species of gut bacteria are present.
-
NewsCockroaches can transmit antimicrobial resistance genes between groups
A new paper describes a study of antimicrobial resistance (AMR) transmission among cockroaches, with implications for AMR transmission in humans.
-
NewsInfection with stomach bacteria may increase risk of Alzheimer’s disease
Infection with the stomach bacterium Helicobacter pylori could increase the risk of developing Alzheimer’s disease. In people over the age of 50, the risk following a symptomatic infection can be an average of 11 per cent higher.
-
NewsDr Thomas Thompson named as winner of inaugural John Snow Prize
Dr Thomas Thompson of Queen’s University Belfast in Northern Ireland has been named as this year’s winner of the inaugural John Snow Prize for microbiology. The prize is part of the Applied Microbiology International Horizon Awards, which celebrate the brightest minds in the field and promote the ...
-
News€20 million EIB venture debt financing to support microbiome research and development
The EIB has signed €20 million in venture debt financing with Belgian microbiome health company The Akkermansia Company to accelerate the R&D and commercial activities around the Akkermansia muciniphila bacterium.
-
NewsCall for papers for themed Pseudomonas collection in Letters in Applied Microbiology
The journal Letters in Applied Microbiology is to run a themed collection on ’Emerging Horizons in Pseudomonas Biotechnology – Innovations from Early-Career Researchers’.
-
NewsResearchers develop potential vaccine against antibiotic-resistant enterococci
Researchers have discovered how to create an enterococcal vaccine that is relatively easy to produce and takes advantage of membrane vesicles.
-
NewsPatients can pause immune-suppressing medicines for COVID-19 booster vaccine
A major clinical trial shows that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their treatment for two weeks immediately after having the vaccine.
-
NewsAdvanced MRI technology detects changes in the brain after COVID-19
Researchers have found differences in brain tissue structure between patients with persisting symptoms after COVID-19 and healthy people.